Immunodiagnostic Systems

IDS is a global medical diagnostics business dedicated to the development and provision of innovative automated and manual assays. Our development focus is in the clinical areas of bone and calcium metabolism, growth, hypertension and chronic kidney disease. Our IDS-iSYS system is designed with the flexibility to accommodate unique and challenging requirements, the IDS-iSYS automation brings testing efficiency and uncompromised quality to specialty immunoassay testing. IDS provides a compact bench top system that fully automates immunoassay testing. IDS has its global headquarters in the UK, and has subsidiaries in the USA, Germany, France, and Denmark. Other markets, including key diagnostic markets of Spain, Italy, Australia, and Japan, are serviced by a network of highly qualified and experienced distributors within each territory.
Type
Public
HQ
Boldon Colliery, GB
Founded
1977
Employees
336 (est)
Immunodiagnostic Systems was founded in 1977 and is headquartered in Boldon Colliery, GB

Immunodiagnostic Systems Locations

Boldon Colliery, GB
Gaithersburg, US
Frankfurt, DE
Paris, FR

Immunodiagnostic Systems Metrics

Immunodiagnostic Systems Summary

Market capitalization

£58.8 M

Closing share price

£2.03
Immunodiagnostic Systems's latest market capitalization is £58.8 M.

Immunodiagnostic Systems Financials

Immunodiagnostic Systems's revenue was £38.3 M in FY, 2016 which is 15.56% decrease from the previous period.
FY, 2014FY, 2015FY, 2016

Revenue

£52.3 M£45.4 M£38.3 M

Revenue growth, %

-13.2%-15.6%

Cost of sales

£16.7 M£17 M£15.8 M

Gross profit

£35.6 M£28.3 M£22.5 M

Gross profit Margin, %

68.1%62.5%58.6%

Operating expense total

£27.3 M£25.1 M£59.3 M

Immunodiagnostic Systems Market Value History

Immunodiagnostic Systems News

Immunodiagnostic Systems Company Life

You may also be interested in